GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » Total Payout Ratio

Can B (CANB) Total Payout Ratio : 0.00 (As of Apr. 29, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Can B Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Can B's current Total Payout Ratio is 0.00.


Can B Total Payout Ratio Historical Data

The historical data trend for Can B's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can B Total Payout Ratio Chart

Can B Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 -0.03 0.54 0.03 -

Can B Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Can B's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Can B's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Can B's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Can B's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Can B's Total Payout Ratio falls into.


;
;

Can B Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Can B's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -9.737
=0.00

Can B's Total Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -3.263
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Can B Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Can B's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Can B Business Description

Traded in Other Exchanges
N/A
Address
960 South Broadway, Suite 120, Hicksville, NY, USA, 11801
Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.
Executives
Mckenzie Webster Ltd 10 percent owner DMS HOUSE, DR. ROYCE DRIVE, GEORGE TOWN, GRAND CAYMAN E9 KY1-1102
Stanley L Teeple director, officer: CFO, Director, and Secretary 94 ARTHUR HILL COURT, HENDERSON NV 89014
Andrew Holtmeyer officer: EVP Business Development 65 LAUREN AVE, SUITE 301, HUNTINGTON STATION NY 11746
Heggenhougen Rolv director 90 NORTH CHURCH STREET, GEORGETOWN E9 KY1-1102
David J Posel officer: COO 6103 CARMEL LN SE, LACEY WA 98503
Rolv Heggenhougen 10 percent owner 445 NE 12TH AVENUE, FORT LAUDERDALE FL 33301
Marco Alfonsi director, 10 percent owner, officer: CEO, Board Member 44 EAST END AVENUE, HICKSVILLE NY 11801
Carl Dilley director 15500 ROOSEVELT BLVD., SUITE 301, CLEARWATER FL 33760

Can B Headlines

From GuruFocus